These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9377699)

  • 1. [Evaluation of cost effectiveness in primary health care].
    Busse R; Graf von der Schulenburg JM; Drummond M
    Z Arztl Fortbild Qualitatssich; 1997 Aug; 91(5):447-55. PubMed ID: 9377699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possibilities and limits of guidelines in medicine].
    Lauterbach KW
    Z Arztl Fortbild Qualitatssich; 1998 Mar; 92(2):99-105. PubMed ID: 9577897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health policy and occupational health: tools and methods to assure quality and appropriateness of interventions].
    Franco G
    Med Lav; 2004; 95(1):3-10. PubMed ID: 15112742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness in surgery. The insurers' point of view.
    van den Oever R
    Acta Chir Belg; 1995; 95(5):205-10. PubMed ID: 7502616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality assurance in rheumatology].
    Keitel W
    Z Rheumatol; 1996; 55(3):143-8. PubMed ID: 8768143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quality assurance and cost containment--counterproductive or synergistic effects?].
    Selbmann HK
    Laryngorhinootologie; 2000 Jan; 79(1):4-7. PubMed ID: 10689673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines in surgery: from the viewpoint of health care economics].
    Neubauer G
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():72-3. PubMed ID: 9574100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing and using quality measures for children's health care: perspectives on the state of the practice.
    Shaller D
    Pediatrics; 2004 Jan; 113(1 Pt 2):217-27. PubMed ID: 14702504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [More care for a limited budget; a case for a better use of the efficiency criteria].
    Rutten FF; Brouwer WB
    Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2254-8. PubMed ID: 12481524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comments by the Working Group for Methods of Economic Evaluation in Health Care (AG MEG) to IQWiG's Draft Guidelines "Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System"].
    Krauth C; John J; Aidelsburger P; Brüggenjürgen B; Hansmeier T; Hessel F; Kohlmann T; Moock J; Rothgang H; Schweikert B; Seitz R; Wasem J;
    Gesundheitswesen; 2008 Jun; 70(6):e1-16. PubMed ID: 18661452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health system and equity perspectives in health technology assessment.
    Hanvoravongchai P
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S74-87. PubMed ID: 19253490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities and limits of evaluation research: development of evaluation methods with an example].
    Niechzial M; Nagel E; Pichlmayr R
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():617-24. PubMed ID: 9574223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core and comprehensive health care services: 4. Economic issues.
    Wyman M; Feeley J; Brimacombe G; Doucette K
    CMAJ; 1995 May; 152(10):1601-4. PubMed ID: 7743446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determining priorities in the development of medical guidelines. 1: Criteria, procedures and actors: a methodological review of international experiences].
    Helou A; Perleth M; Schwartz FW
    Z Arztl Fortbild Qualitatssich; 2000 Jan; 94(1):53-60. PubMed ID: 10721165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
    Gibis B; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is there a voucher for the impact of quality assurance/-improvement methods in foreign countries?].
    Simoes E; Boukamp K; Mayer ED; Schmahl FW
    Gesundheitswesen; 2004 Jun; 66(6):370-9. PubMed ID: 15206040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.